Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 31 - 40 of 222 for bay. (0.07 seconds)

Reflections on the meaning of the Amgen and Tularik...
A promising drug developed with Bayer...
Bioinformatics, once the promise of drug discovery, is...
This section lists the private biotech companies that...
Target raised on postive Q1 report. More details...
There could be a big upside in the generics battle. More...
It turns out just about everything is RIGHT with Onyx:....
Attacked by public and activists over Norvir, an HIV...
BIO 2004 ended quietly on all fronts. More details...
Opportunity abounds but many obstacles remain. More...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital